Literature DB >> 4138741

The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent.

A F Fasola, R Carmichael.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4138741

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN： 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  9 in total

1.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.

Authors:  J P Van Durme; M G Bogaert; M T Rosseel
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

3.  Dose-dependent pharmacokinetics of aprindine in healthy volunteers.

Authors:  T Kobari; T Itoh; T Hirakawa; H Namekawa; T Suzuki; T Satoh; N Iida; F Ohtsu; H Hayakawa
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

6.  Electrophysiologic actions of aprindine in rabbit atrioventricular node.

Authors:  H Tanaka; M Nishimura; N Homma; Y Habuchi; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

7.  The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.

Authors:  T Ebner; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

8.  Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.

Authors:  P R Reid; H L Greene; P J Varghese
Journal:  Br Heart J       Date:  1977-12

9.  Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia.

Authors:  P D Dennis; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.